Advise  ·  Transform  ·  Invest
Industry insight that underpins investment and resilient value creation
Judgement you can lean on over the long run
Dr. Paul Geymayer
Advisor Board Member Investor
Dr. Paul Geymayer
Advising investors, boards and management teams
Working with private equity investors, boards and management teams in the off-patent medicines industry — generics, biosimilars, value-added medicines and OTC.
Board mandates and co-investment
Taking board mandates and co-investing alongside partners where I can contribute as well as commit — capital and active involvement together.
25 years building, leading and transforming businesses
Up to €900 million revenue and 2,700 people across Europe, Asia Pacific and Middle East North Africa — in public, private equity-backed and family-owned environments.
Executive committee roles at Zentiva, Sandoz and MS Pharma
Delivering profitable growth, operational improvement and strong cash conversion. Fluent in the diverse market archetypes of off-patent medicines, from retail and hospital tenders to substitution markets, specialty portfolios and consumer health brands.
Board service across several European jurisdictions
Board member of the Zentiva group holding company, with statutory directorships across several European jurisdictions — fiduciary duty held alongside executive responsibility.
IMD board governance training.
A doctorate in organic chemistry and biochemistry
A genuine scientific foundation to the commercial work — structured thinking, evidence before assertion, and moving between technical depth and commercial strategy without losing either.

Experience in the Room · Impact on the Ground

Working with private equity investors, boards and management teams as a senior advisor, board member and investor. Independent in judgement, direct in counsel, and long term in perspective.

Advise
Providing strategic guidance to private equity investors, boards and management teams in off-patent medicines. On assets under evaluation, on businesses already owned, and on the value still to be created in them. Commercial due diligence, value creation planning, and counsel on the decisions that follow.
Transform
Guiding the work that turns a plan into delivery. Carve-outs, turnarounds, integrations and market entries. Occasionally taking the operating seat through a transition, where a company I already advise or govern needs it.
Invest
Co-investing alongside private equity partners and entrepreneurs where I can contribute as well as commit. Capital and active involvement together, in situations where an operator's perspective changes the outcome.

What I contribute

Sector knowledge turned quickly into decisions you can act on — brought to bear on the questions investors and boards are actually weighing.

Paul Geymayer
Industry insight that underpins investment
Bringing sector-specific knowledge of off-patent medicines, from market archetypes to pricing and tender dynamics, turned quickly into decisions you can act on.
Judgement you can lean on over the long run
Applying operating experience from many companies and continents to strategy, portfolio and organisation.
A value creation plan that holds up
Building plans structured across the full set of levers, resilient enough to deliver profitable growth and cash through changing conditions.
Opportunities uncovered, risks anticipated
Assessing growth potential and downside exposure from diligence through to the boardroom, beyond what the numbers alone show.
Commercial and operational excellence as the engine of growth
Tightening portfolio focus, pricing discipline, footprint and go-to-market execution until they deliver.
Transformation experience, applied
Steering carve-outs, turnarounds and integrations as advisor and board member, with the credibility of having done it first-hand.
Dr. Paul Geymayer

Clarity of direction
Respect for people
Respect for facts

Directly and closely involved with management teams rather than advising from a distance. Independent and accountable in the boardroom, challenging management and backing them in equal measure.

Local talent wherever possible, on the view that businesses are better led by people who understand the market from inside. Teams built on accountability, trust, respect and empowerment. People who deliver, and who want to work with me again.

A scientific training underneath the commercial work. Structured thinking, evidence before assertion, and moving between technical depth and commercial strategy without losing either.

Reaching a view quickly, then testing it. Speed comes from knowing the industry, not from skipping the analysis.

Analytics and AI used as working tools, for research, analysis and structured thinking. A way of reaching a sound view faster, not a substitute for judgement.

Outside the boardroom, an ultra-trail runner. The preparation, the resilience, and navigating complex terrain over long distances are the same disciplines the work requires.

Independent in judgement
Direct in counsel
Long term in perspective